Immune response to SARS-CoV-2 in severe disease and long COVID-19
Summary: COVID-19 is mild to moderate in otherwise healthy individuals but may nonetheless cause life-threatening disease and/or a wide range of persistent symptoms. The general determinant of disease severity is age mainly because the immune response declines in aging patients. Here, we developed a...
Main Authors: | Tomonari Sumi, Kouji Harada |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004222009956 |
Similar Items
-
The strand-biased transcription of SARS-CoV-2 and unbalanced inhibition by remdesivir
by: Yan Zhao, et al.
Published: (2021-08-01) -
Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research
by: Brian D. Williamson, et al.
Published: (2023-09-01) -
Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination
by: Nadine Benhamouda, et al.
Published: (2024-08-01) -
The nonequilibrium mechanism of noise-enhanced drug synergy in HIV latency reactivation
by: Xiaolu Guo, et al.
Published: (2022-06-01) -
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
by: Maya Imbrechts, et al.
Published: (2022-08-01)